In Vivo Expansion of Endogenous Regulatory T Cell Populations Induces Long-Term Suppression of Contact Hypersensitivity

Contact hypersensitivity (CHS) of murine skin serves as a model of allergic contact dermatitis. Hapten-specific CD8 T cells and neutrophils represent the major effector cells driving this inflammatory reaction whereas Foxp3+ regulatory T cells (Tregs) control the severity of inflammation. However, whether in vivo expansion of endogenous Tregs can downregulate CHS-mediated inflammation remains to be elucidated. In this study, we addressed this issue by using injection of an IL-2/anti–IL-2 mAb JES6-1 complex (IL-2/JES6-1) as a means of Treg induction in 2,4,6-trinitrochlorobenzene–induced CHS. IL-2/JES6-1 injection before or after hapten sensitization led to a considerable reduction of skin inflammation, even when rechallenged up to 3 wk after the last treatment. Conversely, Treg depletion re-established the CHS response in IL-2/JES6-1–treated mice. IL-2/JES6-1 injection resulted in increased frequencies of natural and peripheral Tregs in spleen and draining lymph nodes (LNs), elevated IL-10 and TGF-β production by CD4 T cells, reduced CD86 expression by dendritic cells, and led to lower numbers of hapten-specific IFN-γ–producing CD8 T effector cells in LNs. Neutrophil and CD8 T cell infiltration was reduced in inflamed ear tissue, whereas CTLA-4+Foxp3+ Treg frequencies were augmented. Adoptive transfer of LN cells of sensitized mice into recipients treated with IL-2/JES6-1 showed impaired CHS. Our results show that in vivo Treg expansion results in a prolonged CHS suppression, a sustained reduction of hapten-specific CD8 T cells, and a decrease in effector cell influx in inflamed tissue.

[1]  F. Finkelman,et al.  IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complement-mediated neutrophil migration. , 2016, The Journal of allergy and clinical immunology.

[2]  Patricia AdamsGraves,et al.  A phase-3 study of L glutamine therapy for sickle cell anemia and sickle ß0-thalassemia , 2015 .

[3]  W. Koh,et al.  Selective Treg reconstitution during lymphopenia normalizes DC costimulation and prevents graft-versus-host disease. , 2015, The Journal of clinical investigation.

[4]  V. Kalia,et al.  Quiescence of Memory CD8(+) T Cells Is Mediated by Regulatory T Cells through Inhibitory Receptor CTLA-4. , 2015, Immunity.

[5]  S. Skov,et al.  Depletion of regulatory T cells in a hapten‐induced inflammation model results in prolonged and increased inflammation driven by T cells , 2015, Clinical and experimental immunology.

[6]  Milton L. Greenberg,et al.  Imaging regulatory T cell dynamics and suppression of T cell priming mediated by CTLA4 , 2015, Nature Communications.

[7]  L. Puskás,et al.  Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity , 2015, The Journal of experimental medicine.

[8]  K. Hirata,et al.  CD3 Antibody and IL‐2 Complex Combination Therapy Inhibits Atherosclerosis by Augmenting a Regulatory Immune Response , 2014, Journal of the American Heart Association.

[9]  N. Mukaida,et al.  Ag and IL‐2 immune complexes efficiently expand Ag‐specific Treg cells that migrate in response to chemokines and reduce localized immune responses , 2014, European journal of immunology.

[10]  C. Haase,et al.  The role of neutrophils and G-CSF in DNFB-induced contact hypersensitivity in mice , 2014, Immunity, inflammation and disease.

[11]  A. Abbas,et al.  Cutting Edge: Memory Regulatory T Cells Require IL-7 and Not IL-2 for Their Maintenance in Peripheral Tissues , 2013, The Journal of Immunology.

[12]  M. Mycko,et al.  Neutrophil--CD4+CD25+ T regulatory cell interactions: a possible new mechanism of infectious tolerance. , 2013, Immunobiology.

[13]  H. Wolff,et al.  The temporal and spatial dynamics of Foxp3+ Treg cell-mediated suppression during contact hypersensitivity responses in a murine model. , 2012, The Journal of investigative dermatology.

[14]  Daniel J. Kuster,et al.  Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo , 2012, The Journal of experimental medicine.

[15]  P. Tipping,et al.  Cytokine Therapy With Interleukin-2/Anti–Interleukin-2 Monoclonal Antibody Complexes Expands CD4+CD25+Foxp3+ Regulatory T Cells and Attenuates Development and Progression of Atherosclerosis , 2012, Circulation.

[16]  T. Sparwasser,et al.  In vivo reprogramming of UV radiation-induced regulatory T-cell migration to inhibit the elicitation of contact hypersensitivity. , 2011, The Journal of allergy and clinical immunology.

[17]  A. Enk,et al.  Regulatory T cells from IL-10-deficient mice fail to suppress contact hypersensitivity reactions due to lack of adenosine production. , 2011, The Journal of investigative dermatology.

[18]  G. Anderson,et al.  Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4 , 2011, Science.

[19]  H. Waldmann,et al.  Enhanced murine contact hypersensitivity by depletion of endogenous regulatory T cells in the sensitization phase. , 2011, Journal of dermatological science.

[20]  A. Simon,et al.  Novel role of regulatory T cells in limiting early neutrophil responses in skin , 2010, Immunology.

[21]  S. Kaech,et al.  Generation of effector CD8+ T cells and their conversion to memory T cells , 2010, Immunological reviews.

[22]  Y. Belkaid,et al.  Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells , 2010, The Journal of Immunology.

[23]  A. Enk,et al.  CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism. , 2009, The Journal of allergy and clinical immunology.

[24]  D. Link,et al.  CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions. , 2009, Blood.

[25]  J. Sprent,et al.  In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression , 2009, The Journal of experimental medicine.

[26]  T. Wynn,et al.  Suppression of Murine Allergic Airway Disease by IL-2:Anti-IL-2 Monoclonal Antibody-Induced Regulatory T Cells1 , 2008, The Journal of Immunology.

[27]  T. Nomura,et al.  CTLA-4 Control over Foxp3+ Regulatory T Cell Function , 2008, Science.

[28]  K. Kabashima,et al.  Cutaneous hypersensitivities to hapten are controlled by IFN-gamma-upregulated keratinocyte Th1 chemokines and IFN-gamma-downregulated langerhans cell Th2 chemokines. , 2008, The Journal of investigative dermatology.

[29]  C. Loddenkemper,et al.  Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease , 2007, The Journal of experimental medicine.

[30]  P. Lewkowicz,et al.  Lipopolysaccharide-Activated CD4+CD25+ T Regulatory Cells Inhibit Neutrophil Function and Promote Their Apoptosis and Death1 , 2006, The Journal of Immunology.

[31]  A. Enk,et al.  CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue , 2006, European journal of immunology.

[32]  Loise M. Francisco,et al.  Blockade of CTLA-4 on CD4+CD25+ Regulatory T Cells Abrogates Their Function In Vivo1 , 2006, The Journal of Immunology.

[33]  Shimon Sakaguchi,et al.  Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. , 2006, International immunology.

[34]  F. Bérard,et al.  CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. , 2006, The Journal of investigative dermatology.

[35]  J. Sprent,et al.  Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes , 2006, Science.

[36]  Michael Loran Dustin,et al.  Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo , 2006, The Journal of experimental medicine.

[37]  J. Nicolas,et al.  Contribution of CD4+ and CD8+ T-cells in contact hypersensitivity and allergic contact dermatitis , 2005, Expert review of clinical immunology.

[38]  R. Fairchild,et al.  The intensity of neutrophil infiltration controls the number of antigen‐primed CD8 T cells recruited into cutaneous antigen challenge sites , 2004, Journal of leukocyte biology.

[39]  J. Myśliwska,et al.  CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. , 2004, Clinical immunology.

[40]  Stefan F. Martin,et al.  A high frequency of allergen‐specific 
CD8+ Tc1 cells is associated with the murine immune response to the contact sensitizer trinitrophenyl , 2003, Experimental dermatology.

[41]  I. Kimber,et al.  Differential regulation of epidermal langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritant- and allergen-induced cutaneous immune responses. , 2002, Toxicology and applied pharmacology.

[42]  E. Shevach,et al.  Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells , 2001, The Journal of Immunology.

[43]  F. Powrie,et al.  Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.

[44]  R. Fairchild,et al.  Development of effector CD8+ T cells in contact hypersensitivity occurs independently of CD4+ T cells. , 1997, Journal of immunology.

[45]  R. Fairchild,et al.  T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells , 1996, The Journal of experimental medicine.

[46]  F. Alt,et al.  Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.

[47]  R. Tigelaar,et al.  Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. , 1990, Journal of immunology.

[48]  A. Enk,et al.  Gap junctions between regulatory T cells and dendritic cells prevent sensitization of CD8(+) T cells. , 2010, The Journal of allergy and clinical immunology.

[49]  森 智子.  Cutaneous hypersensitivities to hapten are controlled by IFN-γ-upregulated keratinocyte Th1 chemokines and IFN-γ-downregulated Langerhans cell Th2 chemokines , 2009 .